T. Rowe Price Associates’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.6M | Sell |
383,902
-49,269
| -11% | -$2M | ﹤0.01% | 1011 |
|
|
2025
Q1 | $22.3M | Sell |
433,171
-27,602
| -6% | -$1.42M | ﹤0.01% | 932 |
|
|
2024
Q4 | $25.5M | Buy |
460,773
+221,458
| +93% | +$12.3M | ﹤0.01% | 929 |
|
|
2024
Q3 | $7.87M | Sell |
239,315
-51,960
| -18% | -$1.71M | ﹤0.01% | 1184 |
|
|
2024
Q2 | $7.92M | Sell |
291,275
-56,408
| -16% | -$1.53M | ﹤0.01% | 1144 |
|
|
2024
Q1 | $12.6M | Buy |
+347,683
| New | +$12.6M | ﹤0.01% | 1062 |
|